Matches in SemOpenAlex for { <https://semopenalex.org/work/W4301663335> ?p ?o ?g. }
Showing items 1 to 58 of
58
with 100 items per page.
- W4301663335 endingPage "22" @default.
- W4301663335 startingPage "603" @default.
- W4301663335 abstract "Management of oral contraception requires an understanding of the relationships between the method's effectiveness, noncontraceptive benefits, and hormonal adverse effects. The new multiphasic combinations or OCs containing 35 micrograms of ethinyl estradiol and 0.5-1.0 mg of norethindrone or equivalent result in a maximum combination of efficacy and safety for the patient with minimal annoying problems for the patient and the prescriber. Patient education regarding early warning symptoms of adverse effects, breakthrough bleeding, and lack of withdrawal bleeding adds an additional margin of safety and reduces patient questions and uncertainties.A review of the pharmacology of oral contraceptives is presented with emphasis on selection and management for primary care physicians. The paper is introduced with illustrations and diagrams of the menstrual cycle. Orals are 97-99.9% effective in the 1st year of use, which puts them between injectables and IUDs in efficacy, although failure rates are about 4.7% in women 21 years or less. The estrogens and progestins in current pills are described, and their biological effects defined. The actual estrogenic or androgenic effects of combined pills on different organs is complex, but often useful. All pills marketed in the U.S. from 1960-1987 are tabulated with their composition. Triphasic pills are currently popular, primarily because of marketing: they probably do have fewer systemic effects due to lower overall steroid doses. The generic pills now available are Norethin, NII and Genora, with norethindrone and ethinyl estradiol in 1.35 or 1.50 dosages. Contraindications are listed. Specific pills must be started according to packaging, usually with back-up contraception for the 1st cycle. Women must be taught the serious adverse effects to watch for: a mnemonic ACHES is suggested. Mortal risks of cardiovascular disease primarily affect women over 35 who smoke. Risks for older nonsmokers are similar to those of pregnancy. Pills present no known cancer risks; may uncover existing susceptibility to to diabetes; and reduce risk of pelvic infection. Management of spotting and of other minor side effects is described. Noncontraceptive benefits of oral contraceptives prevent estimates 50,000 hospitalizations and 1210 deaths per year in the U.S." @default.
- W4301663335 created "2022-10-05" @default.
- W4301663335 creator A5067092766 @default.
- W4301663335 creator A5084051412 @default.
- W4301663335 date "1990-09-01" @default.
- W4301663335 modified "2023-09-29" @default.
- W4301663335 title "Oral contraceptives." @default.
- W4301663335 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2236339" @default.
- W4301663335 hasPublicationYear "1990" @default.
- W4301663335 type Work @default.
- W4301663335 citedByCount "0" @default.
- W4301663335 crossrefType "journal-article" @default.
- W4301663335 hasAuthorship W4301663335A5067092766 @default.
- W4301663335 hasAuthorship W4301663335A5084051412 @default.
- W4301663335 hasConcept C126322002 @default.
- W4301663335 hasConcept C162156334 @default.
- W4301663335 hasConcept C177713679 @default.
- W4301663335 hasConcept C197934379 @default.
- W4301663335 hasConcept C2779076696 @default.
- W4301663335 hasConcept C2908647359 @default.
- W4301663335 hasConcept C29456083 @default.
- W4301663335 hasConcept C2986817661 @default.
- W4301663335 hasConcept C71924100 @default.
- W4301663335 hasConcept C81603835 @default.
- W4301663335 hasConcept C98274493 @default.
- W4301663335 hasConcept C99454951 @default.
- W4301663335 hasConceptScore W4301663335C126322002 @default.
- W4301663335 hasConceptScore W4301663335C162156334 @default.
- W4301663335 hasConceptScore W4301663335C177713679 @default.
- W4301663335 hasConceptScore W4301663335C197934379 @default.
- W4301663335 hasConceptScore W4301663335C2779076696 @default.
- W4301663335 hasConceptScore W4301663335C2908647359 @default.
- W4301663335 hasConceptScore W4301663335C29456083 @default.
- W4301663335 hasConceptScore W4301663335C2986817661 @default.
- W4301663335 hasConceptScore W4301663335C71924100 @default.
- W4301663335 hasConceptScore W4301663335C81603835 @default.
- W4301663335 hasConceptScore W4301663335C98274493 @default.
- W4301663335 hasConceptScore W4301663335C99454951 @default.
- W4301663335 hasIssue "3" @default.
- W4301663335 hasLocation W43016633351 @default.
- W4301663335 hasOpenAccess W4301663335 @default.
- W4301663335 hasPrimaryLocation W43016633351 @default.
- W4301663335 hasRelatedWork W1989049047 @default.
- W4301663335 hasRelatedWork W2022109293 @default.
- W4301663335 hasRelatedWork W2203197579 @default.
- W4301663335 hasRelatedWork W2286723350 @default.
- W4301663335 hasRelatedWork W2360070380 @default.
- W4301663335 hasRelatedWork W2406839446 @default.
- W4301663335 hasRelatedWork W2412885547 @default.
- W4301663335 hasRelatedWork W2419401569 @default.
- W4301663335 hasRelatedWork W51347339 @default.
- W4301663335 hasRelatedWork W2175358199 @default.
- W4301663335 hasVolume "17" @default.
- W4301663335 isParatext "false" @default.
- W4301663335 isRetracted "false" @default.
- W4301663335 workType "article" @default.